Press Releases
July 17 2024
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling
July 11 2024
InMode to Report Q2 2024 Financial Results and Hold Conference Call on Aug. 1, 2024
May 16 2024
InMode to Present at Jefferies Healthcare Conference
May 02 2024
InMode Reports Q1 2024 Financial Results
April 15 2024
InMode Responds To BTL Petition for Inter Partes Review Of Patent InMode Is Asserting Against BTL
April 09 2024
InMode to Report First Quarter 2024 Financial Results
April 03 2024
InMode to Present at Upcoming Investor Conferences and Events
March 04 2024
InMode to Present at March Investor Conferences and Events
February 13 2024
InMode Reports Q4 and FY 2023 Financial Results; Quarterly Revenue of $126.8M and Record FY Revenue of $492M
January 16 2024
InMode to Report Q4 & FY 2023 Financial Results; Expects Q4 Revenue Between $126.0M-$126.5M
